Key result
The Igaki-Tamai fully biodegradable coronary stent demonstrated long-term safety over 10 years, with a 50% survival rate free of major adverse cardiac events and 2 cases of scaffold thrombosis.
Why the study?
What are the long-term (>10 years) clinical outcomes and safety of the Igaki-Tamai biodegradable poly-l-lactic acid coronary stent in patients undergoing elective treatment?
Cohort (n=50)
What are the long-term (>10 years) clinical outcomes and safety of the Igaki-Tamai biodegradable poly-l-lactic acid coronary stent in patients undergoing elective treatment?
The first-in-human fully biodegradable poly-l-lactic acid coronary stent demonstrated acceptable long-term safety and scaffold thrombosis rates over 10 years of follow-up.
No takes yet. Share an insight, caveat, or question.
Supports 10-year safety of first biodegradable stent; leaves open need for RCTs of modern scaffolds.
Nishio et al. (2012) conducted a cohort in Coronary artery disease (n=50). Igaki-Tamai stent was evaluated on Survival free of major adverse cardiac events at 10 years. The Igaki-Tamai fully biodegradable coronary stent demonstrated long-term safety over 10 years, with a 50% survival rate free of major adverse cardiac events and 2 cases of scaffold thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: